Lucia Mazzolai

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


365 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ...
 
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review.
Bikdeli B., Sadeghipour P., Lou J., Bejjani A., Khairani C.D., Rashedi S., Lookstein R., Lansky A., Vedantham S., Sobieszczyk P. et al. Seminars in thrombosis and hemostasis. Peer-reviewed.
 
The link between impaired oxygen supply and cognitive decline in peripheral artery disease.
Burtscher J., Millet G.P., Fresa M., Lanzi S., Mazzolai L., Pellegrin M. Progress in cardiovascular diseases. Peer-reviewed.
 
Post-traumatic AV Fistula of the Hand Successfully Treated With Percutaneous Endovascular Laser Ablation: Report of a Case.
Fresa M., Bruschi L., Grognuz S., Meuli J., Wehrli L., Mazzolai L. Hand. Peer-reviewed.
 
Commentary to Seed et al. 'What is the correct level of claudication pain to prescribe? Universal inconsistency within guidelines, a painful issue'.
Lanzi S., Mazzolai L. Vascular. Peer-reviewed.
 
Exercise Therapy for Chronic Symptomatic Peripheral Artery Disease: A Clinical Consensus Document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases in Collaboration With the European Society of Vascular Medicine and the European Society for Vascular Surgery.
Mazzolai L., Belch J., Venermo M., Aboyans V., Brodmann M., Bura-Rivière A., Debus S., Espinola-Klein C., Harwood A.E., Hawley J.A. et al. European journal of vascular and endovascular surgery. Peer-reviewed.
 
Stroke risk management in carotid atherosclerotic disease: A Clinical Consensus Statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases.
Musialek P., Bonati L.H., Bulbulia R., Halliday A., Bock B., Capoccia L., Eckstein H.H., Grunwald I.Q., Lip P.L., Monteiro A. et al. Cardiovascular research. Peer-reviewed.
 
Tortuosity in non-atherosclerotic vascular diseases is associated with age, arterial aneurysms, and hypertension.
Luta X., Zanchi F., Fresa M., Porccedu E., Keller S., Bouchardy J., Déglise S., Qanadli S.D., Kirsch M., Wuerzner G. et al., 2024/06/07. Orphanet journal of rare diseases, 19 (1) p. 227. Peer-reviewed.
 
Adverse reactions after intravascular iodinated contrast media administration and their management.
Rašiová M., Schlager O., Heiss C., Brodmann M., Olinic D.M., Boc V., Buso G., Belch J., Mazzolai L., Madaric J., 2024/05. VASA. Zeitschrift fur Gefasskrankheiten, 53 (3) pp. 193-203. Peer-reviewed.
Short-duration aerobic high-intensity intervals versus moderate exercise training intensity in patients with peripheral artery disease: study protocol for a randomised controlled trial (the Angiof-HIIT Study).
Lanzi S., Pousaz A., Fresa M., Besson C., Desgraz B., Gremeaux-Bader V., Mazzolai L., 2024/04/17. BMJ open, 14 (4) pp. e081883. Peer-reviewed.
 
Exercise therapy for chronic symptomatic peripheral artery disease.
Mazzolai L., Belch J., Venermo M., Aboyans V., Brodmann M., Bura-Rivière A., Debus S., Espinola-Klein C., Harwood A.E., Hawley J.A. et al., 2024/04/14. European heart journal, 45 (15) pp. 1303-1321. Peer-reviewed.
 
Exercise therapy for chronic symptomatic peripheral artery disease.
Mazzolai L., Belch J., Venermo M., Aboyans V., Brodmann M., Bura-Rivière A., Debus S., Espinola-Klein C., Harwood A.E., Hawley J.A. et al., 2024/04. VASA. Zeitschrift fur Gefasskrankheiten, 53 (2) pp. 87-108. Peer-reviewed.
 
Systematic review of the use of ultrasound for venous assessment and venous thrombosis screening in spaceflight.
Elias A., Weber T., Green D.A., Harris K.M., Laws J.M., Greaves D.K., Kim D.S., Mazzolai-Duchosal L., Roberts L., Petersen L.G. et al., 2024/02/05. NPJ microgravity, 10 (1) p. 14. Peer-reviewed.
 
Supervised Exercise Training May Improve Postural Control in Patients with Symptomatic Lower Extremity Peripheral Artery Disease.
Degache F., Mak W., Calanca L., Mazzolai L., Lanzi S., 2024/02. The International journal of angiology, 33 (1) pp. 50-56. Peer-reviewed.
 
Le pouvoir des itinéraires cliniques : assurer une gestion optimale.
Mazzolai L., Fontana P., Righini M., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2275-2276. Peer-reviewed.
 
Maladie artérielle périphérique : du diagnostic au traitement [Peripheral arterial disease of the lower limbs : from diagnosis to treatment]
Keller S., Calanca L., Porceddu E., Fresa M., Deslarzes C., Mazzolai L., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2304-2309. Peer-reviewed.
 
Maladie thromboembolique veineuse : démarche diagnostique et suivi [Venous thromboembolic disease : diagnostic pathways and follow-up]
Vecchio M., Porceddu E., Mazzolai L., Alatri A., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2278-2283. Peer-reviewed.
 
Place de la lymphofluoroscopie dans la prise en charge du lymphœdème [Role of lymphofluoroscopy in the management of lymphedema]
Porceddu E., Keller S., Fresa M., Ferrari V., Lessert C., Honorati M., Tomson D., Mazzolai L., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2298-2303. Peer-reviewed.
 
Prise en charge de la maladie aortique : l’importance d’une filière des soins [Management of aortic disease: the importance of an organized care network]
Zehani C.E., Deglise S., Kirsch M., Monney P., Calanca L., Mazzolai L., Alatri A., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2292-2297. Peer-reviewed.
 
Syndrome de congestion pelvienne : du diagnostic au traitement [Pelvic congestion syndrome : from diagnosis to treatment]
Fresa M., Rieder W., Vial Y., Keller S., Porceddu E., Mazzolai L., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2310-2315. Peer-reviewed.
Moderate Effects of Hypoxic Training at Low and Supramaximal Intensities on Skeletal Muscle Metabolic Gene Expression in Mice.
Drozdovska S., Zanou N., Lavier J., Mazzolai L., Millet G.P., Pellegrin M., 2023/10/21. Metabolites, 13 (10) p. 1103. Peer-reviewed.
 
Exercising at high intensity in patients with chronic symptomatic peripheral artery disease: the new PAD-adapted 30-20-10 session
Heiss Christian (eds.), 2023/10/12., 9th Congress of the European Society for Vascular Medicine. Milan, Italy..
Time-course evolution of functional performance during a 3-month supervised exercise training program in patients with symptomatic peripheral artery disease.
Lanzi S., Pousaz A., Calanca L., Mazzolai L., 2023/10. Vascular medicine, 28 (5) pp. 404-411. Peer-reviewed.
 
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry.
Cohen O., Barg A.A., Nowak-Göttl U., Amado-Fernández C., Mazzolai L., Tiberio G., Schellong S., Skride A., Morales MDV, Monreal M. et al., 2023/10. Journal of thrombosis and haemostasis, 21 (10) pp. 2811-2823. Peer-reviewed.
 
Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study.
Vrotniakaite-Bajerciene K., Rütsche S., Calzavarini S., Quarroz C., Stalder O., Mean M., Righini M., Staub D., Beer J.H., Frauchiger B. et al., 2023/09/19. Journal of clinical medicine, 12 (18). Peer-reviewed.
Safety of the pulmonary embolism rule-out criteria rule: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry.
Truong P., Mazzolai L., Font C., Ciammaichella M., González-Martínez J., Tufano A., Gavín-Sebastián O., Le Mao R., Monreal M., Hugli O. et al., 2023/09. Academic emergency medicine, 30 (9) pp. 935-945. Peer-reviewed.
A new score for improving cardiovascular risk prediction and prevention.
Del Giorno R., Reveilhac M., Stauffer I., Berthoud M., Mazzolai L., Depairon M., Darioli R., 2023/08. Nutrition, metabolism, and cardiovascular diseases, 33 (8) pp. 1546-1555. Peer-reviewed.
 
The benefits of exercise in patients with peripheral arterial disease are far too great to be ignored!
Mazzolai L., Bäck M., Belch J., Venermo M., 2023/07. VASA. Zeitschrift fur Gefasskrankheiten, 52 (4) pp. 212-213. Peer-reviewed.
Outcomes after microsurgical treatment of lymphedema: a systematic review and meta-analysis.
Meuli J.N., Guiotto M., Elmers J., Mazzolai L., di Summa P.G., 2023/05/01. International journal of surgery, 109 (5) pp. 1360-1372. Peer-reviewed.
 
Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases.
Evangelista A., Sitges M., Jondeau G., Nijveldt R., Pepi M., Cuellar H., Pontone G., Bossone E., Groenink M., Dweck M.R. et al., 2023/04/24. European heart journal. Cardiovascular Imaging, 24 (5) pp. e65-e85. Peer-reviewed.
Physical Performance and Skeletal Muscle Transcriptional Adaptations Are Not Impacted by Exercise Training Frequency in Mice with Lower Extremity Peripheral Artery Disease.
Lavier J., Bouzourène K., Millet G.P., Mazzolai L., Pellegrin M., 2023/04/16. Metabolites, 13 (4) p. 562. Peer-reviewed.
 
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases.
De Carlo M., Schlager O., Mazzolai L., Brodmann M., Espinola-Klein C., Staub D., Aboyans V., Sillesen H., Debus S., Venermo M. et al., 2023/04/10. European heart journal. Cardiovascular pharmacotherapy, 9 (3) pp. 201-207. Peer-reviewed.
Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial.
Pantet O., Combescure C., Ltaief Z., Mazzolai L., Jeanneret S., Manzocchi-Besson S., Stricker H., Cereghetti S., Pugin J., Calmy A. et al., 2023/04. Thrombosis research, 224 pp. 13-16. Peer-reviewed.
Sex-based differences in supervised exercise therapy outcomes for symptomatic peripheral artery disease.
Lanzi S., Pousaz A., Calanca L., Mazzolai L., 2023/04. Vascular medicine, 28 (2) pp. 147-149. Peer-reviewed.
Sit to Stand Muscle Power Is Related to Functional Performance at Baseline and After Supervised Exercise Training in Patients with Lower Extremity Peripheral Artery Disease.
Lanzi S., Pousaz A., Calanca L., Mazzolai L., 2023/04. European journal of vascular and endovascular surgery, 65 (4) pp. 521-527. Peer-reviewed.
Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer.
Fratta S., Biniecka P., Moreno-Vargas A.J., Carmona A.T., Nahimana A., Duchosal M.A., Piacente F., Bruzzone S., Caffa I., Nencioni A. et al., 2023/03/15. European journal of medicinal chemistry, 250 p. 115170. Peer-reviewed.
 
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome.
Buso G., Faggin E., Bressan A., Galliazzo S., Cinetto F., Felice C., Fusaro M., Erdmann A., Pauletto P., Rattazzi M. et al., 2023/03/12. Biomedicines, 11 (3) p. 866. Peer-reviewed.
 
Health effects of e-cigarettes and their use for smoking cessation from a vascular perspective.
Krabbe B., Espinola-Klein C., Malyar N., Brodmann M., Mazzolai L., Belch JJF, Müller O.J., Heiss C., DGA-German Society of Angiology Board, ESVM-European Society of Vascular Medicine Board, 2023/03. VASA. Zeitschrift fur Gefasskrankheiten, 52 (2) pp. 81-85. Peer-reviewed.
Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea.
Mylonas A., Hawerkamp H.C., Wang Y., Chen J., Messina F., Demaria O., Meller S., Homey B., Di Domizio J., Mazzolai L. et al., 2023/02/22. JCI insight, 8 (4) pp. e151846. Peer-reviewed.
 
Pathophysiology, risk, diagnosis, and management of venous thrombosis in space: where are we now?
Harris K.M., Arya R., Elias A., Weber T., Green D.A., Greaves D.K., Petersen L.G., Roberts L., Kamine T.H., Mazzolai L. et al., 2023/02/16. NPJ microgravity, 9 (1) p. 17. Peer-reviewed.
 
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings.
Buso G., Mazzolai L., Rueda-Camino J.A., Fernández-Capitán C., Jiménez D., Bikdeli B., Lobo J.L., Fernández-Reyes J.L., Ciammaichella M., Monreal M. et al., 2023/02. Seminars in thrombosis and hemostasis, 49 (1) pp. 34-46. Peer-reviewed.
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia.
Matsumoto S., Biniecka P., Bellotti A., Duchosal M.A., Nahimana A., 2023/01/27. Cancers, 15 (3) p. 787. Peer-reviewed.
The Role of Neutrophils in Lower Limb Peripheral Artery Disease: State of the Art and Future Perspectives.
Buso G., Faggin E., Rosenblatt-Velin N., Pellegrin M., Galliazzo S., Calanca L., Rattazzi M., Mazzolai L., 2023/01/06. International journal of molecular sciences, 24 (2) p. 1169. Peer-reviewed.
Brain Natriuretic Peptide Protects Cardiomyocytes from Apoptosis and Stimulates Their Cell Cycle Re-Entry in Mouse Infarcted Hearts.
Bon-Mathier A.C., Déglise T., Rignault-Clerc S., Bielmann C., Mazzolai L., Rosenblatt-Velin N., 2022/12/20. Cells, 12 (1) p. 7. Peer-reviewed.
L’exercice physique dans les maladies vasculaires [Physical therapy in vascular diseases]
Lanzi S., Fresa M., Keller S., Pedrazzoli K., Mazzolai L., 2022/12/07. Revue medicale suisse, 18 (807) pp. 2327-2330. Peer-reviewed.
Vers de nouveaux anticoagulants
Fontana P., Righini M., Mazzolai L., 2022/12/07. Revue medicale suisse, 18 (807) pp. 2311-2312. Peer-reviewed.
Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Wenger N., Sebastian T., Beer J.H., Mazzolai L., Aujesky D., Hayoz D., Engelberger R.P., Korte W., Voci D., Kucher N. et al., 2022/12. Thrombosis research, 220 pp. 65-71. Peer-reviewed.
 
The therapeutic role of exercise training in vascular diseases
Lanzi Stefano, Pedrazzoli Kaliska, Mazzolai Lucia, 2022/12/01. Journal of Sport & Exercise Medicine Switzerland (SEMS). Peer-reviewed.
 
Sit-to-stand muscle power is related to functional performance at baseline and after supervised exercise training in patients with lower extremity peripheral artery disease
mazzolai lucia (eds.), 2022/11/04., Congrès de l’Union des Sociétés Suisses des Maladies Vasculaires. Zurich..
 
Vascular risk assessment and management.
Bigolin P., Zalunardo B., Mazzolai L., Belch J., Visonà A., 2022/11. VASA. Zeitschrift fur Gefasskrankheiten, 51 (6) pp. 351-356. Peer-reviewed.
 
Access and characteristics of supervised exercise training in patients with lower extremity peripheral artery disease: a European overview
Kahan Thomas (eds.), 2022/10/06., 8th Congress of the European Society for Vascular Medicine. Stockholm, Sweden..
Supervised exercise training in patients with lower extremity peripheral artery disease.
Lanzi S., Belch J., Brodmann M., Madaric J., Bura-Riviere A., Visonà A., Mazzolai L., 2022/09. VASA. Zeitschrift fur Gefasskrankheiten, 51 (5) pp. 267-274. Peer-reviewed.
Venous malformation of the penis treated with a combined Nd:YAG laser and sclerotherapy technique.
Fresa M., Mazzolai L., 2022/09. Skin health and disease, 2 (3) pp. e114. Peer-reviewed.
 
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B., Caraballo C., Trujillo-Santos J., Galanaud J.P., di Micco P., Rosa V., Cusidó G.V., Schellong S., Mellado M., Del Valle Morales M. et al., 2022/08/01. JAMA cardiology, 7 (8) pp. 857-865. Peer-reviewed.
 
Real-world practices of TcPO<sub>2</sub> measurements: A French national survey.
Catella J., Della Schiava N., Calanca L., Steinmetz E., Millon A., Mahé G., Long A., Mazzolai L., 2022/08. Vascular medicine, 27 (4) pp. 377-379. Peer-reviewed.
 
UEMS Training Requirements for Angiology/Vascular Medicine: European Standards of Postgraduate Medical Specialist Training (2022 Updated Version).
Wautrecht J.C., Olinic D.M., Catalano M., Baines C., Belch J., Blinc A., Buschmann I., Celovska D., Colgan M.P., Dimakakos E. et al., 2022/06. International angiology, 41 (3) pp. 258-274. Peer-reviewed.
 
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function.
Mazzolai L., Ageno W., Alatri A., Bauersachs R., Becattini C., Brodmann M., Emmerich J., Konstantinides S., Meyer G., Middeldorp S. et al., 2022/05/27. European journal of preventive cardiology, 29 (8) pp. 1248-1263. Peer-reviewed.
 
In postmenopausal women, lower limb peripheral arterial disease, assessed by ankle-brachial index, may be a strong predictor of cardiovascular risk.
Buso G., Darioli R., Calanca L., Depairon M., Schwitter J., Mazzolai L., Alatri A., 2022/05. European journal of internal medicine, 99 pp. 63-69. Peer-reviewed.
Management of chronic peripheral artery disease patients with indication for endovascular revascularization.
Heiss C., Olinic D.M., Belch JJF, Brodmann M., Mazzolai L., Stanek A., Madaric J., Krentz A., Schlager O., Lichtenberg M. et al., 2022/05. VASA. Zeitschrift fur Gefasskrankheiten, 51 (3) pp. 121-137. Peer-reviewed.
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial.
Blondon M., Cereghetti S., Pugin J., Marti C., Darbellay Farhoumand P., Reny J.L., Calmy A., Combescure C., Mazzolai L., Pantet O. et al., 2022/05. Research and practice in thrombosis and haemostasis, 6 (4) pp. e12712. Peer-reviewed.
 
Venous thromboembolism in patients with autoimmune disorders: a comparison between bleeding complications during anticoagulation and recurrences after its discontinuation.
Ruiz-Sada P., Mazzolai L., Braester A., Ballaz A., Madridano O., Accassat S., Fernández-Reyes J.L., López-Sáez J.B., Del Carmen Díaz-Pedroche M., Monreal M. et al., 2022/05. British journal of haematology, 197 (4) pp. 489-496. Peer-reviewed.
Descending stair walking in patients with symptomatic lower extremity peripheral artery disease: A pilot study.
Lanzi S., Nussbaumer P., Calanca L., Mazzolai L., Malatesta D., 2022/04. Vascular medicine, 27 (2) pp. 171-173. Peer-reviewed.
Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: A systematic review and meta-analysis.
Fassora M., Calanca L., Jaques C., Mazzolai L., Kayser B., Lanzi S., 2022/04. Vascular medicine, 27 (2) pp. 158-170. Peer-reviewed.
Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Sebastian T., Beer J.H., Mazzolai L., Aujesky D., Hayoz D., Engelberger R.P., Korte W., Kucher N., Barco S., 2022/04. Internal and emergency medicine, 17 (3) pp. 799-803. Peer-reviewed.
 
Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema.
Buso G., Favre L., Maufus M., Honorati M., Lessert C., Depairon M., Raffoul W., Tomson D., Mazzolai L., 2022/03. Microvascular research, 140 p. 104298. Peer-reviewed.
Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema.
Buso G., Favre L., Vionnet N., Gonzalez-Rodriguez E., Hans D., Puder J.J., Dubath C., Eap C.B., Raffoul W., Collet T.H. et al., 2022. Obesity facts, 15 (6) pp. 762-773. Peer-reviewed.
 
Search for Venous Endothelial Biomarkers Heralding Venous Thromboembolism in Space: A Qualitative Systematic Review of Terrestrial Studies.
Harris K., Laws J.M., Elias A., Green D.A., Goswami N., Jordan J., Kamine T.H., Mazzolai L., Petersen L.G., Winnard A.J. et al., 2022. Frontiers in physiology, 13 p. 885183. Peer-reviewed.
Chez qui effectuer un dépistage de l’anévrisme de l’aorte abdominale ? [Who do you screen for an abdominal aortic aneurysm ?]
Staubli S., Mazzolai L., Fresa M., Déglise S., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2132-2134. Peer-reviewed.
Dépistage de l’artériopathie oblitérante des membres inférieurs : rôle du médecin de premier recours [Screening for peripheral arterial disease : role of the primary care physician]
Buso G., Del Giorno R., Déglise S., Calanca L., Mazzolai L., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2123-2127. Peer-reviewed.
Dépistage de l’athérosclérose dans l’hypercholestérolémie - Vers une prévention cardiovasculaire personnalisée et partagée [Subclinical atherosclerosis in hypercholesterolemia - Towards a personalized, shared decision-making cardiovascular prevention]
Del Giorno R., Keller S., Barigou M., Buso G., Mazzolai L., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2117-2122. Peer-reviewed.
Détection de l’ athérosclérose asymptomatique, y-a-t-il une place en pratique quotidienne ?
Mazzolai L., Fontana P., Righini M., 2021/12/08. Revue medicale suisse, 17 (762) p. 2115. Peer-reviewed.
Maladie thromboembolique veineuse et grossesse : diagnostic, traitement et suivi [Venous thromboembolic disease during pregnancy : diagnosis, treatment and follow-up]
Vecchio M., Guenot C., Staubli S., Gavillet M., Alberio L., Mazzolai L., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2135-2138. Peer-reviewed.
Passeport vasculaire : un outil pour la prévention secondaire des patients avec maladie artérielle périphérique [Vascular passport : a tool for secondary prevention among patients with peripheral artery disease]
Keller S., Del Giorno R., Buso G., Deslarzes C., Calanca L., Lanzi S., Mazzolai L., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2128-2131. Peer-reviewed.
 
Descending stair walking in patients with symptomatic lower extremity peripheral artery disease: a promising new exercise modality
VASA Journal (eds.), 2021/12/03., Congrès de l'Union 2021.
Supervised Exercise Training Improves 6 min Walking Distance and Modifies Gait Pattern during Pain-Free Walking Condition in Patients with Symptomatic Lower Extremity Peripheral Artery Disease.
Lanzi S., Boichat J., Calanca L., Mazzolai L., Malatesta D., 2021/11/30. Sensors, 21 (23) p. 7989. Peer-reviewed.
 
The effects of COVID-19 pandemic on patients with lower extremity peripheral arterial disease: A near miss disaster.
Trunfio R., Deslarzes-Dubuis C., Buso G., Fresa M., Brusa J., Stefanescu A., Zellweger M., Corpataux J.M., Deglise S., Mazzolai L., 2021/11. Annals of vascular surgery, 77 pp. 71-78. Peer-reviewed.
 
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.
Aboyans V., Bauersachs R., Mazzolai L., Brodmann M., Palomares JFR, Debus S., Collet J.P., Drexel H., Espinola-Klein C., Lewis B.S. et al., 2021/10/14. European heart journal, 42 (39) pp. 4013-4024. Peer-reviewed.
High-intensity exercise in hypoxia improves endothelial function via increased nitric oxide bioavailability in C57BL/6 mice.
Lavier J., Beaumann M., Menétrey S., Bouzourène K., Rosenblatt-Velin N., Pialoux V., Mazzolai L., Peyter A.C., Pellegrin M., Millet G.P., 2021/10. Acta physiologica, 233 (2) pp. e13700. Peer-reviewed.
 
Post-thrombotic syndrome.
Visonà A., Quere I., Mazzolai L., Amitrano M., Lugli M., Madaric J., Prandoni P., European Society of Vascular Medicine (ESVM), 2021/09. VASA. Zeitschrift fur Gefasskrankheiten, 50 (5) pp. 331-340. Peer-reviewed.
Partial home confinement during the COVID-19 pandemic, physical function, and physical activity in patients with symptomatic lower extremity peripheral artery disease.
Lanzi S., Pousaz A., Buso G., Mazzolai L., Calanca L., 2021/08. Vascular medicine, 26 (4) pp. 437-439. Peer-reviewed.
Improvement in 6-Minute Walking Distance after Supervised Exercise Training Is Related to Changes in Quality of Life in Patients with Lower Extremity Peripheral Artery Disease.
Lanzi S., Calanca L., Berchtold A., Mazzolai L., 2021/07/28. Journal of clinical medicine, 10 (15) p. 3330. Peer-reviewed.
 
Progress in aorta and peripheral cardiovascular disease research.
Mazzolai L., Alatri A., Rivière A.B., De Carlo M., Heiss C., Espinola-Klein C., Schlager O., Sillesen H., Staub D., Rodriguez-Palomares J.F. et al., 2021/07/27. Cardiovascular research, 117 (9) pp. 2045-2053. Peer-reviewed.
 
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism.
Peris M., López-Nuñez J.J., Maestre A., Jimenez D., Muriel A., Bikdeli B., Weinberg I., Ay C., Mazzolai L., Lorenzo A. et al., 2021/07. The European respiratory journal, 58 (1) p. 2002723. Peer-reviewed.
 
International public awareness of peripheral artery disease.
Bauersachs R., Brodmann M., Clark C., Debus S., De Carlo M., Gomez-Cerezo J.F., Madaric J., Mazzolai L., Ricco J.B., Sillesen H. et al., 2021/07. VASA. Zeitschrift fur Gefasskrankheiten, 50 (4) pp. 294-300. Peer-reviewed.
 
Gait changes after supervised exercise training in patients with symptomatic lower extremity peripheral artery disease.
Lanzi S., Boichat J., Calanca L., Aubertin P., Malatesta D., Mazzolai L., 2021/06. Vascular medicine, 26 (3) pp. 259-266. Peer-reviewed.
 
Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism.
Le Mao R., Jiménez D., Bikdeli B., Porres-Aguilar M., García-Ortega A., Rosa V., Schellong S., Mazzolai L., Rivera-Civico F., Monreal M. et al., 2021/06. Thrombosis and haemostasis, 121 (6) pp. 808-815. Peer-reviewed.
Multimodal Supervised Exercise Training Is Effective in Improving Long Term Walking Performance in Patients with Symptomatic Lower Extremity Peripheral Artery Disease.
Ney B., Lanzi S., Calanca L., Mazzolai L., 2021/05/11. Journal of clinical medicine, 10 (10) p. 2057. Peer-reviewed.
 
Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Sebastian T., Barco S., Banyai M., Beer J.H., Mazzolai L., Baldi T., Aujesky D., Hayoz D., Engelberger R.P. et al., 2021/05. Thrombosis and haemostasis, 121 (5) pp. 641-649. Peer-reviewed.
 
The effect of microgravity on the human venous system and blood coagulation: a systematic review.
Kim D.S., Vaquer S., Mazzolai L., Roberts L.N., Pavela J., Watanabe M., Weerts G., Green D.A., 2021/05. Experimental physiology, 106 (5) pp. 1149-1158. Peer-reviewed.
 
What Is Currently the Role of TcPO2 in the Choice of the Amputation Level of Lower Limbs? A Comprehensive Review.
Catella J., Long A., Mazzolai L., 2021/04/01. Journal of clinical medicine, 10 (7) p. 1413. Peer-reviewed.
 
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.
Pappaccogli M., Di Monaco S., Warchoł-Celińska E., Lorthioir A., Amar L., Aparicio L.S., Beauloye C., Bruno R.M., Chenu P., de Leeuw P. et al., 2021/02/22. Cardiovascular research, 117 (3) pp. 950-959. Peer-reviewed.
 
Ultrasound-guided percutaneous endovenous laser treatment combined with sclerotherapy for the treatment of large intramuscular venous malformations.
Fresa M., El Ezzi O., DE Buys Roessingh A., Qanadli S.D., Ney B., Mazzolai L., 2021/02. International angiology, 40 (1) pp. 1-8. Peer-reviewed.
 
Exercise Prior to Lower Extremity Peripheral Artery Disease Improves Endurance Capacity and Hindlimb Blood Flow by Inhibiting Muscle Inflammation.
Pellegrin M., Bouzourène K., Mazzolai L., 2021. Frontiers in cardiovascular medicine, 8 p. 706491. Peer-reviewed.
 
Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation.
Fernández-Capitán C., Rodriguez Cobo A., Jiménez D., Madridano O., Ciammaichella M., Usandizaga E., Otero R., Di Micco P., Moustafa F., Monreal M. et al., 2021/01. Research and practice in thrombosis and haemostasis, 5 (1) pp. 168-178. Peer-reviewed.
Implémentation des stratégies diagnostiques de l’embolie pulmonaire : encore et toujours un défi.
Righini M., Mazzolai L., Fontana P., 2020/12/09. Revue medicale suisse, 16 (718) pp. 2359-2360. Peer-reviewed.
Nouveautés dans le traitement des malformations veineuses complexes : le laser endoveineux [Advances in the treatment of complex venous malformation: endovenous laser]
Fresa M., Ney B., Qanadli S.D., Saliou G., Superti-Furga A., De Buys A., El Ezzi O., Raffoul W., Mazzolai L., 2020/12/09. Revue medicale suisse, 16 (718) pp. 2387-2390. Peer-reviewed.
 
Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy.
Weissler E.H., Jones W.S., Desormais I., Debus S., Mazzolai L., Espinola-Klein C., Nikol S., Nehler M., Sillesen H., Aboyans V. et al., 2020/12. Atherosclerosis, 315 pp. 10-17. Peer-reviewed.
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
Zermatten Maxime G., Pantet Olivier, Gomez Francisco, Schneider Antoine, Méan Marie, Mazzolai Lucia, Hugli Olivier, Bart Pierre-Alexandre, Papadimitriou-Olivgeris Matthaios, Alberio Lorenzo, 2020/12. Thrombosis Research, 196 pp. 222-226. Peer-reviewed.
 
The ESC Working Group on Aorta & Peripheral Vascular Diseases.
Aboyans V., Mazzolai L., 2020/11/21. European heart journal, 41 (44) pp. 4221-4223. Peer-reviewed.
 
Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review.
Messas E., Goudot G., Halliday A., Sitruk J., Mirault T., Khider L., Saldmann F., Mazzolai L., Aboyans V., 2020/11. European heart journal supplements, 22 (Suppl M) pp. M35-M42. Peer-reviewed.
Syndrome de congestion pelvienne : une cause fréquente de douleur chronique [Pelvic congestion syndrome]
Ney B., Diserens C., Vial Y., Mazzolai L., 2020/10/28. Revue medicale suisse, 16 (712) pp. 2042-2045. Peer-reviewed.
 
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.
Mellado M., Trujillo-Santos J., Bikdeli B., Jiménez D., Núñez M.J., Ellis M., Marchena P.J., Vela J.R., Clara A., Moustafa F. et al., 2020/10. Internal and emergency medicine, 15 (7) p. 1357. Peer-reviewed.
 
Multimodal Supervised Exercise Significantly Improves Walking Performances Without Changing Hemodynamic Parameters in Patients With Symptomatic Lower Extremity Peripheral Artery Disease.
Calanca L., Lanzi S., Ney B., Berchtold A., Mazzolai L., 2020/10. Vascular and endovascular surgery, 54 (7) pp. 605-611. Peer-reviewed.
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S., Bingisser R., Colucci G., Frenk A., Gerber B., Held U., Mach F., Mazzolai L., Righini M., Rosemann T. et al., 2020/09/09. Trials, 21 (1) p. 770. Peer-reviewed.
Impact of aerobic exercise type on blood flow, muscle energy metabolism, and mitochondrial biogenesis in experimental lower extremity artery disease.
Pellegrin M., Bouzourène K., Aubert J.F., Bielmann C., Gruetter R., Rosenblatt-Velin N., Poitry-Yamate C., Mazzolai L., 2020/08/20. Scientific reports, 10 (1) p. 14048. Peer-reviewed.
 
Why optional inferior vena cava filters are not always retrieved? A real world 19 years experience in a Swiss tertiary care university hospital.
Buso G., Alatri A., Calanca L., Fresa M., Qanadli S.D., Pesavento R., Mazzolai L., 2020/06. European journal of internal medicine, 76 pp. 64-70. Peer-reviewed.
 
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I., Cote L., Iftikhar O., Brenner B., Tafur A., Bikdeli B., Fernández-Capitán C., Pedrajas J.M., Otero R., Quintavalla R. et al., 2020/05. Journal of vascular surgery. Venous and lymphatic disorders, 8 (3) pp. 353-359.e1. Peer-reviewed.
 
Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspect.
Tufano A., López-Jiménez L., Bikdeli B., García-Bragado F., Mazzolai L., Amitrano M., Gómez-Cuervo C., Marchena P.J., Madridano O., Monreal M. et al., 2020/04/15. International journal of cardiology, 305 pp. 115-119. Peer-reviewed.
Aspirine en prévention cardiovasculaire primaire : la fin d’une époque ? [Aspirin for primary cardiovascular prevention : the end of an era ?]
Ravach G., Fournier S., Mazzolai L., Nanchen D., 2020/03/04. Revue medicale suisse, 16 (684) pp. 459-462. Peer-reviewed.
 
ABI et risque cardiovasculaire
Calanca Luca, 2020/02. La Gazzette médicale, 9 (1).
 
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Konstantinides Stavros V, Meyer Guy, Becattini Cecilia, Bueno Héctor, Geersing Geert-Jan, Harjola Veli-Pekka, Huisman Menno V, Humbert Marc, Jennings Catriona Sian, Jiménez David et al., 2020/01/21. European Heart Journal, 41 (4) pp. 543-603.
 
The year in cardiology: aorta and peripheral circulation.
Heiss C., Pitcher A., Belch JJF, De Carlo M., Reinecke H., Baumgartner I., Mazzolai L., Aboyans V., 2020/01/21. European heart journal, 41 (4) pp. 501-508b. Peer-reviewed.
 
D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
Avnery O., Martin M., Bura-Riviere A., Barillari G., Mazzolai L., Mahé I., Marchena P.J., Verhamme P., Monreal M., Ellis M.H. et al., 2020/01. Journal of internal medicine, 287 (1) pp. 32-41. Peer-reviewed.
 
The Bleeding Risk in Antithrombotic Therapies: A Narrative Review.
Alatri A., Mazzolai L., 2020. Current vascular pharmacology, 18 (3) pp. 237-248. Peer-reviewed.
 
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years.
Jara-Palomares L., Alfonso M., Maestre A., Jimenez D., Garcia-Bragado F., Font C., Reyes R.L., Blasco L.H., Vidal G., Otero R. et al., 2019/12/27. Scientific reports, 9 (1) p. 20064. Peer-reviewed.
Artériopathie oblitérante des membres inférieurs : complications locales et systémiques [Lower extremity peripheral artery disease : local and systemic complications]
Calanca L., Alatri A., Lanzi S., Deglise S., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2247-2250. Peer-reviewed.
Artériopathie oblitérante des membres inférieurs : nouveautés dans la thérapie médicamenteuse [Patient with lower extremity artery disease : news in therapeutic approach]
Maufus M., Alatri A., Fresa M., Erdmann A., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2242-2246. Peer-reviewed.
 
Faut-il dépister l’artériopathie oblitérante des membres inférieurs chez les patients avec diabète de type [Should patients with type 2 diabetes be screened for lower extremity arterial disease?]
Buso G., Collet T.H., Wojtusciszyn A., Maufus M., Ney B., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2236-2240. Peer-reviewed.
 
Maladies vasculaires ­périphériques et prévention secondaire : un appel à agir
Mazzolai L., Fontana P., Righini M., 2019/12/04. Revue medicale suisse, 15 (674) p. 2227. Peer-reviewed.
 
Traitement par l’exercice physique chez le patient avec une artériopathie oblitérante des membres inférieurs [Exercise training therapy in patients with lower extremity peripheral artery disease]
Lanzi S., Ney B., Deslarzes-Dubuis C., Mazzolai L., Calanca L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2252-2255. Peer-reviewed.
 
Épaisseur intima-média et plaques carotido-fémorales pour stratifier le risque cardiovasculaire [Intima-media thickness and carotidofemoral plaques for cardiovascular risk stratification]
Erdmann A., Fresa M., Buso G., Ney B., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2229-2231. Peer-reviewed.
 
Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.
Venermo M., Sprynger M., Desormais I., Björck M., Brodmann M., Cohnert T., De Carlo M., Espinola-Klein C., Kownator S., Mazzolai L. et al., 2019/12. European journal of preventive cardiology, 26 (18) pp. 1971-1984. Peer-reviewed.
 
Lower extremity artery disease in patients with type 2 diabetes.
Buso G., Aboyans V., Mazzolai L., 2019/12. European journal of preventive cardiology, 26 (2_suppl) pp. 114-124. Peer-reviewed.
 
Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results.
Dotta-Celio J., Alatri A., Locatelli I., Salvi M., Bugnon O., Schneider M.P., Mazzolai L., 2019/12. International journal of clinical pharmacy, 41 (6) pp. 1625-1633. Peer-reviewed.
Towards Quantification of Inflammation in Atherosclerotic Plaque in the Clinic - Characterization and Optimization of Fluorine-19 MRI in Mice at 3 T.
Darçot E., Colotti R., Pellegrin M., Wilson A., Siegert S., Bouzourene K., Yerly J., Mazzolai L., Stuber M., van Heeswijk R.B., 2019/11/25. Scientific reports, 9 (1) p. 17488. Peer-reviewed.
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux A.J., Aubry D., Heulot M., Widmann C., ElMokh O., Piacente F., Cea M., Nencioni A., Bellotti A., Bouzourène K. et al., 2019/11/19. Oncotarget, 10 (62) pp. 6723-6738. Peer-reviewed.
 
Editor's Choice - Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.
Venermo M., Sprynger M., Desormais I., Björck M., Brodmann M., Cohnert T., De Carlo M., Espinola-Klein C., Kownator S., Mazzolai L. et al., 2019/11. European journal of vascular and endovascular surgery, 58 (5) pp. 641-653. Peer-reviewed.
 
The compelling arguments for the need of medical vascular physicians in Europe.
Heiss C., Madaric J., Belch J., Brodmann M., Mazzolai L., 2019/11. VASA. Zeitschrift fur Gefasskrankheiten, 48 (6) pp. 487-491. Peer-reviewed.
 
Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Sebastian T., Banyai M., Beer J.H., Mazzolai L., Baldi T., Aujesky D., Hayoz D., Engelberger R.P., Kaeslin T. et al., 2019/11. Seminars in thrombosis and hemostasis, 45 (8) pp. 851-858. Peer-reviewed.
 
Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry.
Bikdeli B., Jiménez D., Garcia-Tsao G., Barba R., Font C., Díaz-Pedroche MDC, Mazzolai L., Little DHW, Tufano A., Tafur A.J. et al., 2019/11. Seminars in thrombosis and hemostasis, 45 (8) pp. 793-801. Peer-reviewed.
Lipedema: A Call to Action!
Buso G., Depairon M., Tomson D., Raffoul W., Vettor R., Mazzolai L., 2019/10. Obesity, 27 (10) pp. 1567-1576. Peer-reviewed.
 
P4699Gait pattern and muscle oxygen saturation changes act synergistically to improve exercise tolerance after multimodal training in patients with symptomatic lower extremity artery disease
Lanzi S, Boichat J, Calanca L, Aubertin P, Malatesta D, Mazzolai L, 2019/10/01. European Heart Journal, 40 (Supplement_1).
 
Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism.
Mellado M., Trujillo-Santos J., Bikdeli B., Jiménez D., Núñez M.J., Ellis M., Marchena P.J., Vela J.R., Clara A., Moustafa F. et al., 2019/10. Internal and emergency medicine, 14 (7) pp. 1101-1112. Peer-reviewed.
 
Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry.
Murgier M., Bertoletti L., Darmon M., Zeni F., Valle R., Del Toro J., Llamas P., Mazzolai L., Villalobos A., Monreal M. et al., 2019/09/15. International journal of cardiology, 291 pp. 121-126. Peer-reviewed.
 
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) : The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)
Konstantinides Stavros V., Meyer Guy, Becattini Cecilia, Bueno Héctor, Geersing Geert-Jan, Harjola Veli-Pekka, Huisman Menno V., Humbert Marc, Jennings Catriona Sian, Jiménez David et al., 2019/09. European Respiratory Journal, 54 (3) p. 1901647.
 
ESVM Guideline on peripheral arterial disease.
Frank U., Nikol S., Belch J., Boc V., Brodmann M., Carpentier P.H., Chraim A., Canning C., Dimakakos E., Gottsäter A. et al., 2019/09. VASA. Zeitschrift fur Gefasskrankheiten, 48 (Suppl 102) pp. 1-79. Peer-reviewed.
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V., Pisano M., Lessert C., Petit B., Bouzourene K., Nahimana A., Vozenin M.C., Stergiopulos N., Swartz M.A., Mazzolai L., 2019/06. European journal of vascular and endovascular surgery, 57 (6) pp. 859-867. Peer-reviewed.
 
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database.
Fuentes H.E., Tafur A.J., Caprini J.A., Alatri A., Trujillo-Santos J., Farge-Bancel D., Rosa V., Font L., Vilaseca A., Monreal M. et al., 2019/06. International angiology, 38 (3) pp. 173-184. Peer-reviewed.
 
Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular Medicine.
Constans J., Bura-Rivière A., Visona A., Brodmann M., Abraham P., Olinic D.M., Madaric J., Steiner S., Quéré I., Mazzolai L. et al., 2019/05. VASA. Zeitschrift fur Gefasskrankheiten, 48 (3) pp. 223-227. Peer-reviewed.
Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
Le Gal L., Pellegrin M., Santoro T., Mazzolai L., Kurtz A., Meda P., Wagner C., Haefliger J.A., 2019/04/16. Journal of the American Heart Association, 8 (8) pp. e010823. Peer-reviewed.
 
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.
Pastori D., Eikelboom J.W., Anand S.S., Patel M.R., Tanguay J.F., Ricco J.B., Debus E.S., Mazzolai L., Bauersachs R., Verhamme P. et al., 2019/04. Thrombosis and haemostasis, 119 (4) pp. 576-585. Peer-reviewed.
 
Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice.
Lavier J., Beaumann M., Ménetrey S., Mazzolai L., Peyter A.C., Pellegrin M., Millet G.P., 2019/03/15. Journal of visualized experiments 145. Peer-reviewed.
 
The year 2018 in cardiology: aorta and peripheral circulation.
Aboyans V., Vrsalovic M., Madaric J., Mazzolai L., De Carlo M., ESC Working Group on Aorta and Peripheral Vascular Diseases, 2019/03/14. European heart journal, 40 (11) pp. 872-879. Peer-reviewed.
 
ESVM integrated care pathways - a call for action.
Visonà A., Pesavento R., Mazzolai L., Cimminiello C., Pécsvárady Z., Olinic D., Johansson E., 2019/03. VASA. Zeitschrift fur Gefasskrankheiten, 48 (2) pp. 113-114. Peer-reviewed.
A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A., Calzavarini S., Limacher A., Mean M., Righini M., Staub D., Beer J.H., Frauchiger B., Osterwalder J., Kucher N. et al., 2019/02. Journal of thrombosis and haemostasis, 17 (2) pp. 306-318. Peer-reviewed.
 
Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry.
Mastroiacovo D., Dentali F., di Micco P., Maestre A., Jiménez D., Soler S., Sahuquillo J.C., Verhamme P., Fidalgo Á., López-Sáez J.B. et al., 2019/02. The European respiratory journal, 53 (2). Peer-reviewed.
 
Gait pattern and muscle oxygen saturation changes act synergistically to improve exercise tolerance after multimodal training in patients with symptomatic lower extremity artery disease
Lanzi Stefano, Boichat Joel, Calanca Luca, Aubertin Pauline, Malatesta Davide, Mazzolai Lucia, 2019. dans 24th annual congress of the ECSS, Prague, Czech Republic.
 
Time-course evolution of physical function and postural stability during supervised exercise training in patients with symptomatic lower extremity artery disease
Lanzi Stefano, Calanca Luca, Boichat Joel, Mazzolai Lucia, 2019. dans 5th Congress of the European Society for Vascular Medicine. Ljubljana, Slovenia. .
 
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function.
Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R., Brekelmans MPA, Büller H.R., Elias A., Farge D. et al., 2018/12/14. European heart journal, 39 (47) pp. 4208-4218. Peer-reviewed.
 
Anticoagulation à faible dose : is less more ? []
Fontana P., Mazzolai L., Righini M., 2018/12/05. Revue medicale suisse, 14 (630) p. 2191. Peer-reviewed.
 
Traitement médical optimal de l’artériopathie oblitérante des membres inférieurs en 2018 [Best medical treatment of lower extremity arterial disease in 2018]
Buso G., Calanca L., Ney B., Fresa M., Mazzolai L., 2018/12/05. Revue medicale suisse, 14 (630) pp. 2202-2206. Peer-reviewed.
Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature.
Lanzi S., Calanca L., Borgeat Kaeser A., Mazzolai L., 2018/12. European heart journal. Case reports, 2 (4) pp. yty123. Peer-reviewed.
 
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry.
Weinberg I., Giri J., Kolluri R., Arcelus J.I., Falgá C., Soler S., Braester A., Bascuñana J., Gutiérrez-Guisado J., Monreal M. et al., 2018/11. Journal of thrombosis and thrombolysis, 46 (4) pp. 551-558. Peer-reviewed.
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M., Bouzourène K., Aubert J.F., Nahimana A., Duchosal M.A., Mazzolai L., 2018/09/04. International journal of molecular sciences, 19 (9) pp. E2621. Peer-reviewed.
 
Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis.
Méan M., Limacher A., Alatri A., Aujesky D., Mazzolai L., 2018/08. Thrombosis and haemostasis, 118 (8) pp. 1419-1427. Peer-reviewed.
 
Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis.
Bikdeli B., Sharif-Kashani B., Bikdeli B., Valle R., Falga C., Riera-Mestre A., Mazzolai L., Verhamme P., Wells P.S., Torrero JFSM et al., 2018/06. Seminars in thrombosis and hemostasis, 44 (4) pp. 341-347. Peer-reviewed.
 
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
Lauber S., Limacher A., Tritschler T., Stalder O., Méan M., Righini M., Aschwanden M., Beer J.H., Frauchiger B., Osterwalder J. et al., 2018/06. The American journal of medicine, 131 (6) pp. 703.e7-703.e16. Peer-reviewed.
 
Suitability for catheter-directed thrombolysis in patients with acute lower extremity deep vein thrombosis according to various international consensus guidelines.
Stefanescu A., Alatri A., Périard D., Kucher N., Mazzolai L., Engelberger R.P., 2018/05. Thrombosis research, 165 pp. 112-115. Peer-reviewed.
 
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
Kuperman A., López-Reyes R., Bosco L.J., Lorenzo A., José B., Farge Bancel D., Alfonso M., Lumbierres M., Stemer G., Monreal Bosch M. et al., 2018/04. Journal of thrombosis and thrombolysis, 45 (3) pp. 360-368. Peer-reviewed.
 
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
Chai-Adisaksopha C., Iorio A., Crowther M.A., de Miguel J., Salgado E., Zdraveska M., Fernández-Capitán C., Nieto J.A., Barillari G., Bertoletti L. et al., 2018/04. The American journal of medicine, 131 (4) pp. 430-437. Peer-reviewed.
 
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V., Ricco J.B., Bartelink MEL, Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debus S. et al., 2018/03. European journal of vascular and endovascular surgery, 55 (3) pp. 305-368. Peer-reviewed.
 
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).
Aboyans V., Björck M., Brodmann M., Collet J.P., Czerny M., De Carlo M., Naylor A.R., Roffi M., Tendera M., Vlachopoulos C. et al., 2018/03/01. European heart journal, 39 (9) pp. e35-e41. Peer-reviewed.
 
The year 2017 in cardiology: aorta and peripheral circulation.
Aboyans V., Braekkan S., Mazzolai L., Sillesen H., Venermo M., De Carlo M., ESC Working Group on Aorta and Peripheral Vascular Diseases, 2018/03/01. European heart journal, 39 (9) pp. 730-738. Peer-reviewed.
 
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V., Ricco J.B., Bartelink MEL, Bjorck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debusa S. et al., 2018/02. Revista espanola de cardiologia, 71 (2) p. 111. Peer-reviewed.
 
Exercise Training Modalities in Lower Limb Peripheral Artery Disease
Lanzi Stefano, Mazzolai Lucia, Calanca Luca, 2018. pp. 439-444 dans Practical Issues in Geriatrics, Springer International Publishing.
 
Il est temps d’agir! []
Mazzolai L., 2018. Praxis, 107 (20) p. 1069. Peer-reviewed.
 
Le lipœdème, cet inconnu [Lipedema, the Unknown]
Depairon M., Tomson D., Lessert C., Mazzolai L., 2018. Praxis, 107 (20) pp. 1071-1076. Peer-reviewed.
 
Supervised exercise training improves physical function in patients with lower extremity artery disease: preliminary results
Lanzi S, Calanca L, Boichat J, Mazzolai L, 2018. dans . 23rd annual congress of the ECSS, Dublin, Ireland.
 
Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: A case report
Lanzi S, Calanca L, Mazzolai L, 2018. dans 4th Congress of the European Society for Vascular Medicine. Prague, Czech Republic.
 
Le défi des maladies vasculaires rares : l’union fait la force ! []
Mazzolai L., Fontana P., Righini M., 2017/12/06. Revue medicale suisse, 13 (586) p. 2107. Peer-reviewed.
 
Lymphœdème primaire [Primary lymphedema]
Depairon M., Lessert C., Tomson D., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2124-2128. Peer-reviewed.
 
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV [Rare vascular diseases, building dedicated multidisciplinary specialized center]
Krieger C., Baud D., Bouchardy J., Christen-Zaech S., De Buys A., Deglise S., El Ezzi O., Fresa M., Hofer M., Hohl D. et al., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2109-2115. Peer-reviewed.
 
Thromboangéite oblitérante :notions pour la pratique [Thromboangiitis obliterans: notions for practice]
Calanca L., Alatri A., Krieger C., Corpataux J.M., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2129-2133. Peer-reviewed.
 
Thromboses veineuses profondes de localisation inhabituelle [Deep vein thrombosis in uncommon localisations]
Erdmann A., Ney B., Qanadli S.D., Calanca L., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2134-2137. Peer-reviewed.
 
Traitement des malformations veineuses chez l’adulte : rôle de la sclérothérapie échoguidée [The treatment of venous malformations in adult patients: the role of US-guided sclerotherapy]
Fresa M., Erdmann A., El Ezzi O., De Buys A., Depairon M., Dabiri A., Ney B., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2116-2120. Peer-reviewed.
 
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M., Angelillo-Scherrer A., Méan M., Limacher A., Abbal C., Righini M., Beer J.H., Osterwalder J., Frauchiger B., Aschwanden M. et al., 2017/11. Journal of thrombosis and haemostasis, 15 (11) pp. 2165-2175. Peer-reviewed.
 
The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry.
Alatri A., Mazzolai L., Kucher N., Aujesky D., Beer J.H., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2017/11. Seminars in thrombosis and hemostasis, 43 (8) pp. 871-876. Peer-reviewed.
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.
Moustafa F., Giorgi Pierfranceschi M., Di Micco P., Bucherini E., Lorenzo A., Villalobos A., Nieto J.A., Valero B., Sampériz Á.L., Monreal M. et al., 2017/10. Research and practice in thrombosis and haemostasis, 1 (2) pp. 172-179. Peer-reviewed.
 
Hypertension et dysplasie fibromusculaire :au-delà des artères rénales [Fibromuscular dysplasia and hypertension : beyond renal arteries]
Wuerzner G., Krieger C., Bouchardy J., Toubiana L., Delmotte P., Van der Niepen P., Déglise S., Qanadli S., Burnier M., Mazzolai L. et al., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1580-1583. Peer-reviewed.
 
P1410Vascular parameters as predictors of walking performances prior and following supervised exercise training in lower extremity artery disease
Lanzi S., Calanca L., Ney B., Berchtold A., Mazzolai L., 2017/08/01. European Heart Journal, 38 (suppl_1).
 
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A., Mazzolai L., Font C., Tafur A., Valle R., Marchena P.J., Ballaz A., Tiraferri E., Font L., Monreal M. et al., 2017/07/26. Thrombosis and haemostasis, 117 (8) pp. 1630-1636. Peer-reviewed.
 
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism.
Barrios D., Chavant J., Jiménez D., Bertoletti L., Rosa-Salazar V., Muriel A., Viallon A., Fernández-Capitán C., Yusen R.D., Monreal M. et al., 2017/05. The American journal of medicine, 130 (5) pp. 588-595. Peer-reviewed.
 
The year in cardiology 2016: peripheral circulation.
De Carlo M., Mazzolai L., Bossone E., Brodmann M., Micari A., Muiesan M.L., Ricco J.B., Stabile E., Agnelli G., Aboyans V. et al., 2017/04/07. European heart journal, 38 (14) pp. 1028-1033. Peer-reviewed.
 
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I., Papadakis M., Brenner B., Fidalgo Á., Rivas A., Wells P.S., Gavín O., Adarraga M.D., Moustafa F., Monreal M. et al., 2017/04. The American journal of medicine, 130 (4) pp. 482.e1-482.e9. Peer-reviewed.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz J.I., Lensing AWA, Prins M.H., Bauersachs R., Beyer-Westendorf J., Bounameaux H., Brighton T.A., Cohen A.T., Davidson B.L., Decousus H. et al., 2017/03/30. The New England journal of medicine, 376 (13) pp. 1211-1222. Peer-reviewed.
 
Prise en charge interventionnelle de l’insuffisance veineuse superficielle des membres inférieurs [Interventional treatment of venous insufficiency]
Ney B., Engelberger R.P., Dabiri A., Lüthi J.F., Erdmann A., Krieger C., Déglise S., Merminod T., Kern P., Mazzolai L., 2017/03/15. Revue medicale suisse, 13 (554) pp. 618-622. Peer-reviewed.
 
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.
Jara-Palomares L., Otero R., Jimenez D., Carrier M., Tzoran I., Brenner B., Margeli M., Praena-Fernandez J.M., Grandone E., Monreal M. et al., 2017/03. Chest, 151 (3) pp. 564-571. Peer-reviewed.
 
Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á., Trujillo-Santos J., Pesavento R., Rosa V., Falgá C., Tolosa C., Mazzolai L., Sampériz Á., Duce R., Monreal M. et al., 2017/03. Thrombosis research, 151 Suppl 1 pp. S6-S10. Peer-reviewed.
 
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.
Mahé I., Chidiac J., Bertoletti L., Font C., Trujillo-Santos J., Peris M., Pérez Ductor C., Nieto S., Grandone E., Monreal M. et al., 2017/03. The American journal of medicine, 130 (3) pp. 337-347. Peer-reviewed.
 
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.
Faller N., Limacher A., Méan M., Righini M., Aschwanden M., Beer J.H., Frauchiger B., Osterwalder J., Kucher N., Lämmle B. et al., 2017/02. The American journal of medicine, 130 (2) pp. 198-206. Peer-reviewed.
 
Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
Newton D.H., Monreal Bosch M., Amendola M., Wolfe L., Perez Ductor C., Lecumberri R., Levy M.M., RIETE Investigators, 2017/01. Journal of vascular surgery. Venous and lymphatic disorders, 5 (1) pp. 18-24.e1. Peer-reviewed.
 
Wytyczne ESC dotyczące rozpoznawania i leczenia chorób tętnic obwodowych w 2017 roku, przygotowane we współpracy z ESVS [2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)]
Aboyans V., Ricco J.B., Bartelink M.L., Björck M., Brodmann M., Cohner T., Collet J.P., Czerny M., De Carlo M., Debus S. et al., 2017. Kardiologia polska, 75 (11) pp. 1065-1160. Peer-reviewed.
 
Intérêt de l’échographie de contraste aux microbulles en médecine vasculaire [Relevance of contrast ultrasound with microbubbles in vascular medecine]
Erdmann A., Ney B., Alatri A., Calanca L., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2131-2134. Peer-reviewed.
 
La maladie thrombo-embolique veineuse : une pathologie souvent oubliée
Righini M., Fontana P., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2099-2100. Peer-reviewed.
 
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M., Galanaud J.P., Guenneguez H., Brisot D., Diard A., Faisse P., Barrellier M.T., Hamel-Desnos C., Jurus C., Pichot O. et al., 2016/12. The Lancet. Haematology, 3 (12) pp. e556-e562. Peer-reviewed.
 
Venous thromboembolism in centenarians: Findings from the RIETE registry.
Lacruz B., Tiberio G., Núñez M.J., López-Jiménez L., Riera-Mestre A., Tiraferri E., Verhamme P., Mazzolai L., González J., Monreal M. et al., 2016/12. European journal of internal medicine, 36 pp. 62-66. Peer-reviewed.
 
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
Peris M., Jiménez D., Maestre A., Font C., Tafur A.J., Mazzolai L., Xifre B., Skride A., Dentali F., Monreal M. et al., 2016/11. The European respiratory journal, 48 (5) pp. 1360-1368. Peer-reviewed.
 
Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N., Aujesky D., Beer J.H., Mazzolai L., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W., Escher R. et al., 2016/08/30. Thrombosis and haemostasis, 116 (3) pp. 472-479.
 
DVT Management and Outcome Trends, 2001 to 2014.
Morillo R., Jiménez D., Aibar M.Á., Mastroiacovo D., Wells P.S., Sampériz Á., Saraiva de Sousa M., Muriel A., Yusen R.D., Monreal M. et al., 2016/08. Chest, 150 (2) pp. 374-383. Peer-reviewed.
 
Maladie de Rendu-Osler. Manifestations cliniques et prise en charge multidisciplinaire [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management]
Frigerio C., Aebischer N., Baud D., Bonafe L., Fellmanne F., Ikonomidis C., Mazzolai L., Michel P., Nichita C., Qanadli S.D. et al., 2016/05/04. Revue medicale suisse, 12 (517) pp. 896-901. Peer-reviewed.
 
Nitric Oxide Deficit Drives Intimal Hyperplasia in Mouse Models of Hypertension.
Allagnat F., Haefliger J.A., Lambelet M., Longchamp A., Bérard X., Mazzolai L., Corpataux J.M., Déglise S., 2016/05. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 51 (5) pp. 733-742. Peer-reviewed.
 
Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions.
Pellegrin M., Szostak J., Bouzourène K., Aubert J.F., Berthelot A., Nussberger J., Laurant P., Mazzolai L., 2016/04/30. Journal of cardiovascular pharmacology and therapeutics, 22 (2) pp. 159-168. Peer-reviewed.
 
Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Aujesky D., Stuck A.K., Beer J.H., Mazzolai L., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2016/04. Seminars in thrombosis and hemostasis, 42 (6) pp. 642-649. Peer-reviewed.
 
Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.
Frasson S., Gussoni G., Di Micco P., Barba R., Bertoletti L., Nuñez M.J., Valero B., Samperiz A.L., Rivas A., Monreal M. et al., 2016/04. Journal of thrombosis and thrombolysis, 41 (3) pp. 404-412.
 
Thrombopénie induite par l'héparine et syndrome de Trousseau
Katchaluba Maria, Glauser Frédéric, Holzer Thomas, Mazzolai Lucia, Alatri Adriano, 2016/03/01. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (09).
 
The year in cardiology 2015: peripheral circulation.
Aboyans V., De Carlo M., Kownator S., Mazzolai L., Meneveau N., Ricco J.B., Vlachopoulos C., Brodmann M., ESC Working Group on Peripheral Circulation, 2016/02/21. European heart journal, 37 (8) pp. 676-685. Peer-reviewed.
 
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.
Jiménez D., de Miguel-Díez J., Guijarro R., Trujillo-Santos J., Otero R., Barba R., Muriel A., Meyer G., Yusen R.D., Monreal M. et al., 2016/01/19. Journal of the American College of Cardiology, 67 (2) pp. 162-170.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University